Report Details:
15 Companies Covered
72 Pages
Pediatric healthcare Market Highlights
Middle East and Africa Pediatric Healthcare Market was estimated at 50.01 USD Billion in 2024. The pediatric healthcare industry is projected to grow from 51.93 USD Billion in 2025 to 75.71 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.84% during the forecast period 2025 - 2035
The Middle-East and Africa Pediatric Healthcare Market has been evaluated as progressively growing market and it is expected that the market will continue to grow at same pace in the near future. Pediatric is field of medicine which concern with physical, mental and social health of infants, children and adolescents. Pediatric drugs manufacturers are investing in R&D to develop new drugs while pediatric equipment manufacturers are also developing innovative and technologically advanced products for the market. Many hospitals are providing wide range of healthcare services in Middle East and Africa region. Due to increase in per capita income, the spending on healthcare also increasing in this region.
The diseases like diabetes, asthma, and obesity are rising rapidly that is major market driver for pediatric healthcare in this region. Improving healthcare infrastructure, top class medical facilities and availability skilled medical professionals are leading the growth for the pediatric healthcare market in this region. Government are also considering healthcare as priority and taking many initiatives to improve healthcare sector which is major driver for the market. Middle East and Africa is expected to grow by 10% annually and which is good factor for the growth of overall healthcare industry. Due to cost efficient and top class medical facilities, medical tourism is also rising in Middle East and Africa. Medical tourism also helps many industries to grow such as hotel industry, aviation industry, tourism and local vendors.
Middle-East and Africa Pediatric Healthcare Market Players:
There are plenty of large and small market players which operate in this market all over the Middle East and Africa region, such Novartis AG (Switzerland), AstraZeneca (UK), Janssen Global Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE)
Considering the scenario of the Middle East and Africa market, UAE region is believed to be the largest market for Middle-East and Africa Pediatric healthcare. Moreover, Saudi Arabia market is also growing and second largest market for Pediatric healthcare. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Pediatric healthcare during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
Segmentation:
Middle East and Africa Pediatric healthcare Market has been segmented on the basis of type of diseases which comprise Short term diseases, chronic diseases, and others. On the basis of Therapeutics which cardiology, allergy and immunology, gastroenterology, infectious disease, and others. On the basis of treatment it segmented into medication, surgery, and others.
